Literature DB >> 27600110

Fatigue in systemic lupus erythematosus : Association with disease activity, quality of life and psychosocial factors.

S Yilmaz-Oner1, B Ilhan2, M Can3, F Alibaz-Oner3, O Polat-Korkmaz2, G Ozen3, G Mumcu4, H M Kremers5, S Tuglular6, H Direskeneli3.   

Abstract

OBJECTIVE: The aim of the study was to determine which disease-related factors and non-disease features can explain the presence of systemic lupus erythematosus (SLE)-related fatigue in Turkish patients.
METHODS: This cross-sectional study was carried out with 99 SLE patients and 71 healthy controls. To assess fatigue and health-related quality of life (HRQoL) the participants were asked to complete two questionnaires: the short form-36 health survey (SF-36) and the multidimensional assessment of fatigue (MAF) scale. Anxiety and depression of participants were assessed by the hospital anxiety and depression scale (HADS).
RESULTS: A total of 99 patients (female/male 95/4) and 71 controls (female/male 40/31) were studied. The mean age and standard deviation (±SD) of patients and controls were 43.3 ± 12.2 years and 43.2 ± 12.1 years, respectively. The mean (SD) disease duration was 7.8 ± 5.3 years and median SLE disease activity index (SLEDAI) score was 0 (range = 0-16). The level of fatigue was higher in patients compared to controls with mean MAF scores of 24.7 ± 12.2 and 12.8 ± 9.9 (p < 0.001), respectively. The HADS-D and HADS-A scores were also significantly higher in SLE patients (6.6 ± 4.3 vs. 3.6 ± 2.9, p < 0.001 and 7.2 ± 4 vs. 4.9 ± 4, p = 0.007, respectively). There were no significant associations between the MAF and SLEDAI scores (r = 0.05, p = 0.63) but MAF scores positively correlated with age, HADS-A and HADS-D scores and negatively correlated with physical component summary (PCS), mental component summary (MCS) and each domain of SF-36 except role emotional in SLE patients.
CONCLUSION: Fatigue is an important factor influencing patient daily life independent from disease activity in our study. The SLE patients with severe fatigue should also be assessed for other possible underlying causes such as anxiety, depression and poor quality of life.

Entities:  

Keywords:  Anxiety; Depression; Fatigue; Quality of life; Systemic lupus erythematosus

Mesh:

Year:  2017        PMID: 27600110     DOI: 10.1007/s00393-016-0185-0

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  43 in total

1.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

Review 2.  Lupus brain fog: a biologic perspective on cognitive impairment, depression, and fatigue in systemic lupus erythematosus.

Authors:  Meggan Mackay
Journal:  Immunol Res       Date:  2015-12       Impact factor: 2.829

3.  How does quality of life of patients with systemic lupus erythematosus compare with that of other common chronic illnesses?

Authors:  Meenakshi Jolly
Journal:  J Rheumatol       Date:  2005-09       Impact factor: 4.666

Review 4.  A review of health related quality of life in systemic lupus erythematosus.

Authors:  K McElhone; J Abbott; L S Teh
Journal:  Lupus       Date:  2006       Impact factor: 2.911

5.  Unmet needs of patients with systemic lupus erythematosus.

Authors:  Sharon Danoff-Burg; Fred Friedberg
Journal:  Behav Med       Date:  2009       Impact factor: 3.104

6.  Factors related to fatigue in women and men with early rheumatoid arthritis: the Swedish TIRA study.

Authors:  Ingrid Thyberg; Orjan Dahlström; Mikael Thyberg
Journal:  J Rehabil Med       Date:  2009-11       Impact factor: 2.912

7.  Definition, incidence, and clinical description of flare in systemic lupus erythematosus. A prospective cohort study.

Authors:  M Petri; M Genovese; E Engle; M Hochberg
Journal:  Arthritis Rheum       Date:  1991-08

8.  Temporal relations between unexplained fatigue and depression: longitudinal data from an international study in primary care.

Authors:  Petros Skapinakis; Glyn Lewis; Venetsanos Mavreas
Journal:  Psychosom Med       Date:  2004 May-Jun       Impact factor: 4.312

Review 9.  Role of the Toll Like receptor (TLR) radical cycle in chronic inflammation: possible treatments targeting the TLR4 pathway.

Authors:  Kurt Lucas; Michael Maes
Journal:  Mol Neurobiol       Date:  2013-02-26       Impact factor: 5.590

Review 10.  Myalgic encephalomyelitis/chronic fatigue syndrome and encephalomyelitis disseminata/multiple sclerosis show remarkable levels of similarity in phenomenology and neuroimmune characteristics.

Authors:  Gerwyn Morris; Michael Maes
Journal:  BMC Med       Date:  2013-09-17       Impact factor: 8.775

View more
  5 in total

1.  Fatigue and its correlates in Indian patients with systemic lupus erythematosus.

Authors:  Benzeeta Pinto; Aadhaar Dhooria; Sandeep Grover; Meenakshi Jolly; John Michael Raj; Aman Sharma
Journal:  Clin Rheumatol       Date:  2020-10-08       Impact factor: 2.980

Review 2.  Effects of Vitamin D on Systemic Lupus Erythematosus Disease Activity and Autoimmunity: A Systematic Review and Meta-Analysis.

Authors:  Shayan A Irfan; Abid A Ali; Naqiha Shabbir; Hina Altaf; Ali Ahmed; Jafrikh Thamara Kunnath; Naga Vijaya L Divya Boorle; April K Miguel; Chia Chi Loh; Nikhila Gandrakota; Mirza M Ali Baig
Journal:  Cureus       Date:  2022-06-13

3.  Fatigue of systemic lupus erythematosus in China: contributors and effects on the quality of life.

Authors:  Xian Du; Qian Zhao; Yuan Zhuang; Haoyang Chen; Biyu Shen
Journal:  Patient Prefer Adherence       Date:  2018-09-06       Impact factor: 2.711

4.  Impact of fatigue on health-related quality of life and illness perception in a monocentric cohort of patients with systemic lupus erythematosus.

Authors:  Elena Elefante; Chiara Tani; Chiara Stagnaro; Francesco Ferro; Alice Parma; Linda Carli; Viola Signorini; Dina Zucchi; Umberto Peta; Adele Santoni; Leonardo Raffaelli; Marta Mosca
Journal:  RMD Open       Date:  2020-02

5.  Does illness perception associate with disease symptoms in Behçet's disease?

Authors:  Gonca Mumcu; Fedayi Yağar; Fatma Alibaz-Öner; Nevsun İnanç; Haner Direskeneli; Tulin Ergun
Journal:  Intern Emerg Med       Date:  2018-11-30       Impact factor: 3.397

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.